Senaste nyheterna Gedea Biotech strengthens its Board with extensive commercial expertise to support next phaseLund, Sweden – November 18, 2025 Gedea Biotech, an innovative Swedish life science company in women’s health, today…18 November 2025New insights into the vaginal microbiome: Emilia Lahtinen’s industrial PhD journeyAt the intersection of academic research and biotech innovation, Emilia Lahtinen is pursuing her industrial PhD as a…6 November 2025Gedea Biotech Announces CE-Marking for pHyph: A Novel Antibiotic-Free Treatment for Bacterial VaginosisGedea Biotech Announces CE-Marking for pHyph: A Novel Antibiotic-Free Treatment for Bacterial Vaginosis 2 September 2025PRESS RELEASE Gedea Biotech Receives US Patent for Preventing Preterm BirthGedea Biotech announced today that the United States Patent and Trademark Office (USPTO) has granted the company’s…27 March 2025Gedea Biotech Reports Significant Results in Study for the Treatment of Bacterial Vaginosis12 March 2025Closing the Health GapOn the Iternational Women's Day we want to address the THE WOMEN’S HEALTH GAP 8 March 2025Gedea wins prestigious scale up awardOn Thursday November 28th, at the Nordic Mentor Network For Entrepreneurship - NOME annual meeting in Copenhagen, we…3 December 2024 Press kitKlicka för att ladda ner logotyper och bilder
